申请人:——
公开号:US20040181073A1
公开(公告)日:2004-09-16
N-(2-aryl-propionyl)-amides of formula (I) are described.
1
The process for their preparation and pharmaceutical preparations thereof are also described.
The amides of the invention are useful in the prevention and treatment of tissue damage due to the exacerbate recruitment of polymorphonuclear neutrophils (leukocytes PMN) at the inflammatory sites. In particular, the invention relates to the R enantiomers of N-(2-aryl-propionyl)amides of formula (I) for use in the ihibition of the chemotaxis of neutrophils induced by IL-8. The compounds of the invention are used in the treatment of psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis.
公式(I)的N-(2-芳基丙酰基)酰胺已被描述。还描述了它们的制备过程和药物制剂。本发明的酰胺在预防和治疗由于在炎症部位加重多形核中性粒细胞(白细胞PMN)的招募而导致的组织损伤方面是有用的。具体而言,本发明涉及用于抑制IL-8诱导的中性粒细胞趋化作用的N-(2-芳基丙酰基)酰胺的R对映体。本发明的化合物用于治疗牛皮癣、溃疡性结肠炎、肾小球肾炎、急性呼吸功能不全、特发性纤维化和类风湿关节炎。